Ex-Officio Member, Action Board Chair
Appointed November 2017
Term Ending 2018
Email Marty Romney
Marty Romney is an assistant professor at the Jefferson University College of Population Health in Philadelphia.
Formerly, she was director of legal and regulatory support groups and involved in policy and regulatory initiatives at GlaxoSmithKline. Prior to working in the pharmaceutical industry, she practiced medical malpractice law and served as a clinical nurse specialist on a pediatric sexual abuse team. She was educated at the Duke University and Columbia University Schools of Nursing, the Antioch College of Law and the Drexel University School of Public Health. She is currently pursuing a doctorate in juridical studies at the Widener University Delaware Law School.
Her research interests include reducing health disparities in community and health care systems through innovative interventions to inform practice and policy; worksite wellness, cancer, obesity, cultural competency and health literacy and bioethics. She completed a fellowship focused on addressing disparities in clinical trials. She currently serves as project evaluator for innovative projects including the integration of hospital-based health literacy services and policies as well as educating and empowering consumers in the Philadelphia five-county region, and community-based medical-legal partnerships. She teaches Public Health Policy and Advocacy, Public Health Law and Ethics, Cultural Humility & Cultural Competency and Bioethics in graduate/ doctoral programs. Ms. Romney is on the editorial board of Population Health Management, has co-authored book chapters addressing population health, institutional review boards, and legal issues in healthcare quality, as well as peer-reviewed articles.
Marty has been a member of the APHA since 2008 and a member of the Law SPIG/Section since 2009. In addition, she has also been an active member of the Ethics SPIG/Section for the past 4 years including representing the Ethics Section on the Action Board since 2014. She has also represented the Action Board on the Joint Policy Committee for the past two years. This year she will serve as the chair of the Action Board, co-chair of the Joint Policy Committee and as ex-officio member of the Executive Board.